KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ginkgo Bioworks Holdings (DNA) Intangibles (2020 - 2025)

Ginkgo Bioworks Holdings filings provide 6 years of Intangibles readings, the most recent being $56.9 million for Q4 2025.

  • On a quarterly basis, Intangibles fell 21.49% to $56.9 million in Q4 2025 year-over-year; TTM through Dec 2025 was $56.9 million, a 21.49% decrease, with the full-year FY2025 number at $56.9 million, down 21.49% from a year prior.
  • Intangibles hit $56.9 million in Q4 2025 for Ginkgo Bioworks Holdings, down from $61.5 million in the prior quarter.
  • In the past five years, Intangibles ranged from a high of $111.0 million in Q4 2022 to a low of $20.8 million in Q1 2022.
  • Median Intangibles over the past 5 years was $70.6 million (2024), compared with a mean of $68.5 million.
  • Biggest five-year swings in Intangibles: soared 557.01% in 2021 and later dropped 28.81% in 2024.
  • Ginkgo Bioworks Holdings' Intangibles stood at $21.6 million in 2021, then soared by 413.08% to $111.0 million in 2022, then fell by 25.49% to $82.7 million in 2023, then dropped by 12.37% to $72.5 million in 2024, then decreased by 21.49% to $56.9 million in 2025.
  • The last three reported values for Intangibles were $56.9 million (Q4 2025), $61.5 million (Q3 2025), and $66.2 million (Q2 2025) per Business Quant data.